BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3813457)

  • 1. [Toward better monitoring of anticoagulant treatment with antivitamins K. Recommendations of the Hemostasis and Thrombosis Study Group].
    Ann Cardiol Angeiol (Paris); 1986 Oct; 35(8):499-500. PubMed ID: 3813457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recommendations of the Hemostasis and Thrombosis Study Group. Toward better monitoring of anticoagulant treatment with antivitamins K].
    Ann Med Interne (Paris); 1986; 137(6):530-1. PubMed ID: 3813290
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recommendations of the Study Group on Hemostasis and Thrombosis. Toward improved monitoring of anticoagulant treatment with antivitamins K].
    J Chir (Paris); 1986 Nov; 123(11):674. PubMed ID: 3611225
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recommendations of the Hemostasis and Thrombosis Study Group. For better surveillance of anticoagulant therapy by anti-vitamin K agents].
    Nouv Rev Fr Hematol (1978); 1986; 28(5):331-2. PubMed ID: 3808944
    [No Abstract]   [Full Text] [Related]  

  • 5. [Recommendation of the Group for Studies on Hemostasis and Thrombosis. Toward better supervision of anticoagulant therapy by anti-vitamin K agents].
    Pathol Biol (Paris); 1986 Nov; 34(9):1035-6. PubMed ID: 3543814
    [No Abstract]   [Full Text] [Related]  

  • 6. [How to improve the monitoring of anticoagulant therapy with antivitamins K. Recommendation of the Study Group on Hemostasis and Thrombosis].
    Rev Fr Gynecol Obstet; 1987 Feb; 82(2):133-4. PubMed ID: 3563287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-K vitamins].
    Vergoz D
    Phlebologie; 1975; 28(1):23-7. PubMed ID: 1202527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant therapy with antivitamins K].
    Bokarev IN; Kabaeva EV
    Klin Med (Mosk); 1984 Jan; 62(1):18-24. PubMed ID: 6708415
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monitoring of anticoagulants of secondary haemostasis].
    Schuster B
    Hamostaseologie; 2009 Aug; 29(3):268-73. PubMed ID: 19644600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulants (heparin, antivitamins K, principles and rules of use)].
    Lecompte T; Horellou MH
    Rev Prat; 1992 May; 42(10):1280-8. PubMed ID: 1609224
    [No Abstract]   [Full Text] [Related]  

  • 11. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of thromboembolic complications with adapted low-dose of antivitamins K after total hip prosthesis].
    Hernigou P; Février MJ; Kergrohen F
    Rev Chir Orthop Reparatrice Appar Mot; 1993; 79(7):577-85. PubMed ID: 8085039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulants. Antivitamins K: principles and rules of use, posology].
    Mismetti P; Decousus H
    Rev Prat; 1995 Apr; 45(8):1014-7. PubMed ID: 7761767
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypersensitivity and resistance to antivitamins K].
    Keréveur A; Trossaert M; Horellou MH; Conard J; Dupeyron JP; Samama M
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4):487-95. PubMed ID: 7646267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of regulating anticoagulant drugs: focus on warfarin.
    Mann KG
    Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antivitamins K. Mode of action, indications, principles of treatment, role of the dentist].
    Pélissier A; Alantar SA
    Actual Odontostomatol (Paris); 1990 Mar; 44(169):127-40. PubMed ID: 2143620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 18. The anticoagulant treatment of Eales' disease.
    Casanovas J; Castillo R
    Bibl Ophthalmol; 1968; 76():166-71. PubMed ID: 5674839
    [No Abstract]   [Full Text] [Related]  

  • 19. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of the diagnosis and treatment of venous thrombosis. Benefit-risk relationship of anticoagulant treatment].
    Samama MM
    Rev Med Suisse Romande; 1995 Apr; 115(4):297-300. PubMed ID: 7740253
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.